Regulation of Ets function by protein–protein interactions
The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Abstract
Ets proteins are a family of transcription factors that share an 85 amino acid conserved DNA binding domain, the ETS domain. Over 25 mammalian Ets family members control important biological processes, including cellular proliferation, differentiation, lymphocyte development and activation, transformation and apoptosis by recognizing the GGA core motif in the promoter or enhancer of their target genes. Protein - protein interactions regulates DNA binding, subcellular localization, target gene selection and transcriptional activity of Ets proteins. Combinatorial control is a characteristic property of Ets family members, involving interaction between Ets and other key transcriptional factors such as AP-1, NFkappaB and Pax family members. Specific domains of Ets proteins interact with many protein motifs such as bHLH, bZipper and Paired domain. Such interactions coordinate cellular processes in response to diverse signals including cytokines, growth factors, antigen and cellular stresses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ultimately, the protein–protein interface may provide a unique target for intervention, thus, providing a novel approach for blocking aberrant signalling pathways or reversing the malignant phenotype associated with oncogenic transcription factors [123].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [123]
In the citing paper
“ETS proteins display a variety of such cooperative partnerships, as previously reviewed (1, 2, 151, 152).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [151]
Citations
Cites
Regulation of matrix metalloproteinase expression in tumor invasion
Westermarck, J., & Kähäri, V. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.8.781 · Cited by 1,494 · cited 1×
“Adjacent Ets and AP-1 binding sites occur in a large number of promoter/enhancer elements (Wasylyk et al., 1993; Westermarck and Kahari, 1999) and functional cooperation between Ets and AP-1 is critical for controlled expression of many genes, including cytokines (Gottschalk et al., 1993; Wang et…”
BackgroundGolub, T. R., Barker, G. F., Lovett, M., & Gilliland, D. G. (1994) · Cell · doi:10.1016/0092-8674(94)90322-0 · Cited by 1,155
Retinoblastoma protein represses transcription by recruiting a histone deacetylase
Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J. P., Troalen, F., Trouche, D., & Harel-Bellan, A. (1998) · Nature · doi:10.1038/35410 · Cited by 909
The Ets family of transcription factors
WASYLYK, B., HAHN, S. L., & GIOVANE, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb19864.x · Cited by 842 · cited 1×
“Adjacent Ets and AP-1 binding sites occur in a large number of promoter/enhancer elements (Wasylyk et al., 1993; Westermarck and Kahari, 1999) and functional cooperation between Ets and AP-1 is critical for controlled expression of many genes, including cytokines (Gottschalk et al., 1993; Wang et…”
BackgroundA TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia
Lacronique, V., Boureux, A., Della Valle, V., Poirel, H., Quang, C. T., Mauchauffé, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., et al. (1997) · Science · doi:10.1126/science.278.5341.1309 · Cited by 791 · cited 1×
“…lead to a permanent signal activity in signaling transduction, which are characteristic of the leukemic cells (Ghysdael and Boureux, 1997; Golub et al., 1994; 1996; Ho et al., 1999; Jousset et al., 1997; Lacronique et al., 1997; Papadopoulos et al., 1995; Peeters et al., 1997; Romana et al., 1995).”
BackgroundCrystal structure of the heterodimeric bZIP transcription factor c-Fos–c-Jun bound to DNA
Glover, J. N. M., & Harrison, S. C. (1995) · Nature · doi:10.1038/373257a0 · Cited by 735 · cited 1×
“…not p65 (Bassuk et al., 1997) Ets/bZIP factors Crystal structures of basic leucine zipper (bZIP) factors demonstrate that the basic region of bZIP factors mediates protein ±DNA interaction, while the leucine zipper domain contributes to protein ± protein interactions (Glover and Harrison, 1995).”
BackgroundTernary complex factors: growth factor regulated transcriptional activators
Treisman, R. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90097-3 · Cited by 676 · cited 1×
“The regulation of TCFs activity is an important mechanism by which the serum response element responds to growth factor signals (Treisman, 1994).”
BackgroundGiese, K., Kingsley, C., Kirshner, J. R., & Grosschedl, R. (1995) · Genes & Development · doi:10.1101/gad.9.8.995 · Cited by 541 · cited 1×
“…1998 Pongubala et al., 1992 TFE3 Ets1/PU.1 Ig m A Tian et al., 1999 enhancer Dang et al., 1998 PEBP2aB Ets1 TcRa A Wooton et al., 1994 /AML1/ Giese et al., 1995 CBFa2 Mo-MLV A Sheridan et al., 1995 HIV-1 Sun et al., 1995 Kim et al., 1999 AML1 MEF IL3 A Mao et al., 1999 AML1/ETO Promoter R…”
BackgroundThe t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion
Romana, S., Mauchauffe, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R., & Bernard, O. (1995) · Blood · doi:10.1182/blood.v85.12.3662.bloodjournal85123662 · Cited by 530 · cited 1×
“…lead to a permanent signal activity in signaling transduction, which are characteristic of the leukemic cells (Ghysdael and Boureux, 1997; Golub et al., 1994; 1996; Ho et al., 1999; Jousset et al., 1997; Lacronique et al., 1997; Papadopoulos et al., 1995; Peeters et al., 1997; Romana et al., 1995).”
BackgroundStructure and function of helix-loop-helix proteins
Murre, C., Bain, G., van Dijk, M. A., Engel, I., Furnari, B. A., Massari, M. E., Matthews, J. R., Quong, M. W., Rivera, R. R., & Stuiver, M. H. (1994) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(94)90001-9 · Cited by 511 · cited 1×
“…The basic helix ± loop ± helix (bHLH) transcription factors form homo- or heterodimers through their bHLH domains, enabling the basic regions to form a bipartite DNA-binding motif that recognize `E-box', and play a crucial role in controlling of speci®c developmental processes (Murre et al., 1994).”
Background
Research works printed but not linked: 7
- Bhat NK and Papas TS. . 1994 Challenges of Modern Medicine, Vol. 5: Ares-Serono Symposia 5. Verna R and Shamoo A. (eds) pp 63–68.
- Boise LH, Petryniak B, Mao X, June CH, Wang CY, Lindsten T, Bravo R, Kovary K, Leiden JM and Thompson CB. . 1993 Mol. Cell Biol. 13: 1911–1919. · doi:10.1128/mcb.13.3.1911-1919.1993 · Paper page
- Graves B and Peterson J (eds). . Advances in cancer research, Vol 75. Academic Press: San Diego, California 1998 pp1–55.
- Pongubala JM, Nagulapalli S, Klemsz MI, McKercher SR, Maki RA and Atchison ML. . 1992 Mol. Cell. Biol. 12: 368–378. · doi:10.1128/mcb.12.1.368-378.1992 · Paper page
- Shore P and Sharrocks AD. . 1994 Mol. Cell Biol. 14: 3283–3291. · doi:10.1128/mcb.14.5.3283-3291.1994 · Paper page
- Watson DK, Li R, Sementchenko VI, Mavrothalassitis G and Seth A. . 2001 Encylopedia of Cancer. Bertino JR (ed.). Academic Press in press.
- Wotton D, Ghysdael J, Wang S, Speck NA and Owen MJ. . 1994 Mol. Cell Biol. 14: 840–850. · doi:10.1128/mcb.14.1.840-850.1994 · Paper page
Cited by
Items 101–200 of 225
Ets2 transcription factor, telomerase activity and breast cancer
Dwyer, J., & Liu, J. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05236.x · Cited by 37
“Many Ets proteins are TFs, although some function as repressors or both activators and repressors.6–9 The Ets TFs are involved in diverse biological functions, an outcome of interactions with some 200 identified target genes.10 The Ets TFs are frequently deregulated in cancer, especially Ets-1 and Ets-2.”
BackgroundXie, S., Xie, X., Zhao, X. Y., Liu, F., Wang, Y., Ping, J., & Ji, Z. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad261 · Cited by 36
Abnormal Expression of the ERG Transcription Factor in Prostate Cancer Cells Activates Osteopontin
Flajollet, S., Tian, T. V., Flourens, A., Tomavo, N., Villers, A. A., Bonnelye, E., Aubert, S., Leroy, X., & Duterque‐Coquillaud, M. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0537 · Cited by 30
Cosi, I., Pellecchia, A., Lorenzo, E. D., Torre, E., Sica, M., Nesi, G., Notaro, R., & Angioletti, M. D. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00943-w · Cited by 35
“This apparent discrepancy could be explained by the fact that different cell types express different tissue-specific factors that, in turn, may influence the role of ETV4 as it happens for others ETS transcription factors [5, 70].”
BackgroundFisher, M. H., Kirkpatrick, G. D., Stevens, B. M., Jones, C. L., Callaghan, M. U., Rajpurkar, M., Fulbright, J. M., Cooper, M. A., Rowley, J. W., Porter, C. C., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.140332 · Cited by 31
JunD-mediated repression of GADD45α and γ regulates escape from cell death in prostate cancer
Zerbini, L. F., de Vasconcellos, J. F., Czibere, A. G., Wang, Y., Paccez, J. D., Gu, X., Zhou, J., & Libermann, T. A. (2011) · Cell Cycle · doi:10.4161/cc.10.15.16057 · Cited by 34
“Depending on the sequence context and the particular cellular environment, binding of two distinct transcription factor complexes result in higher affinity interaction, synergistic repression or activation of specific target genes.(40) Combinatorial control of transcriptional regulation has been demonstrated to affect…”
BackgroundProteasomal Degradation of the EWS-FLI1 Fusion Protein Is Regulated by a Single Lysine Residue
Gierisch, M. E., Pfistner, F., Lopez-Garcia, L. A., Behrmann, L., Schäfer, B. W., & Niggli, F. K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.752063 · Cited by 38
“ETS transcription factors (TFs) bind most commonly in complexes to a GGA core region to mediate gene expression (4, 5).”
BackgroundCharacterization and Analysis of the Proximal Janus Kinase 3 Promoter
Aringer, M., Hofmann, S. R., Frucht, D. M., Chen, M., Centola, M. B., Morinobu, A., Visconti, R., Kastner, D. L., Smolen, J. S., & O’Shea, J. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6057 · Cited by 31
DeWitt, S. B., Plumlee, S. H., Brighton, H. E., Sivaraj, D., Martz, E. J., Zand, M., Kumar, V., Sheth, M. U., Floyd, W., Spruance, J., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.151583 · Cited by 36
Pleiotropic functions of EAPII/TTRAP/TDP2: Cancer development, chemoresistance and beyond
Li, C., Sun, S., Khuri, F. R., & Li, R. (2011) · Cell Cycle · doi:10.4161/cc.10.19.17763 · Cited by 35
Self-citationKwon, M.-C., Koo, B., Kim, Y.-Y., Lee, S., Kim, N., Kim, J.-H., & Kong, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.059840 · Cited by 33
Wang, Y., Feng, L., Said, M., Balderman, S., Fayazi, Z., Liu, Y., Ghosh, D., & Gulick, A. M. (2005) · Biochemistry · doi:10.1021/bi047352t · Cited by 30
Suico, M. A., Yoshida, H., Seki, Y., Uchikawa, T., Lü, Z., Shuto, T., Matsuzaki, K., Nakao, M., Li, J., & Kai, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312439200 · Cited by 28
Regulation of αB-crystallin gene expression by the transcription factor Ets1 in breast cancer
Bosman, J. D., Yehiely, F., Evans, J. R., & Cryns, V. L. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0330-4 · Cited by 27
“Such specificity may be conferred by the nucleotides flanking the conserved EBS or by coregulatory proteins that interact with ETS family members and cooperatively bind DNA [26, 27].”
BackgroundStructural and functional analysis of domains mediating interaction between NKX‐3.1 and PDEF
Chen, H., & Bieberich, C. J. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20297 · Cited by 26
“Current paradigms emphasize the role of protein partners that can modulate activity by altering sub-cellular localization, DNA binding activity, or function [Chariot et al., 1999; Wilson and Desplan, 1999; Li et al., 2000].”
BackgroundSong, K. S., Lee, T. J., Kim, K., Chung, K. C., & Yoon, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802507200 · Cited by 27
Sugimoto, H., Okamura, K., Sugimoto, S., Satou, M., Hattori, T., Vance, D. E., & Izumi, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503578200 · Cited by 27
Functional analysis of the mouse Fcgrt 5′ proximal promoter
Tiwari, B., & Junghans, R. P. (2004) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2004.10.002 · Cited by 33
Nandy, A., Jenatschke, S., Hartung, B., Milde‐Langosch, K., Bamberger, A., & Gellersen, B. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0310105 · Cited by 25
“Unlike AP-1, members of the Ets family of transcription factors bind to their target sequence as monomers, but share with AP-1 an involvement in a wide range of biological processes including cellular proliferation, differentiation, transformation and apoptosis (Li et al. 2000).”
BackgroundWu, A.-H., & Low, W. C. (2003) · Neuro-Oncology · doi:10.1215/s1152851702000510 · Cited by 25
Guerry, F., Marti, C.-O., Zhang, Y., Moroni, P. S., Jaquiéry, E., & Müller, F. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.03.026 · Cited by 28
“Transcriptional repression by ETS family proteins through chromatin structure and DNA accessibility has previously been shown to occur in a considerable number of different processes and organisms (Hsu and Schulz, 2000; Li et al., 2000; Mavrothalassitis and Ghysdael, 2000).”
BackgroundAnalysis of select members of the E26 (ETS) transcription factors family in colorectal cancer
Deves, C., Renck, D., Garicochea, B., da Silva, V. D., Lopes, T. G., Fillman, H., Fillman, L., Alves, S. L., Basso, L. A., Santos, D. S., et al. (2011) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-011-1053-6 · Cited by 28
Arderiu, G., Espinosa, S., Peña, E., Aledo, R., & Badimón, L. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv065 · Cited by 24
An Ets motif in the proximal decidual prolactin promoter is essential for basal gene expression
Brar, A. K., Kessler, C., & Handwerger, S. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0290099 · Cited by 24
“The ability of Ets proteins to activate transcription, however, does not always depend on the presence of adjacent AP-1 transcription factor binding sites.”
BackgroundMao, L., & Wang, J. Q. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01750.x · Cited by 26
“…of the ETS domain transcription factor family, dimerize with serum response factors (SRF) to assemble multiprotein complexes, binding to serum response element (SRE) on the promoter to regulate DNA transcription (for a review see Li et al. 2000; Yordy and Muise-Helmericks 2000; Sharrocks 2001).”
BackgroundSpatially resolved transcriptomics reveals the architecture of the tumor/microenvironment interfacePreprint
Hunter, M. V., Moncada, R. M., Weiss, J. M., Yanai, I., & White, R. M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.05.368753 · Cited by 24
“Despite their role as transcription factors, ETS proteins also participate in a wide range of protein-protein interactions, and their activity is regulated through phosphorylation as a result of signaling cascades (Li et al., 2000).”
BackgroundEnhancers display constrained sequence flexibility and context-specific modulation of motif function
Reiter, F., de Almeida, B. P., & Stark, A. (2023) · Genome Research · doi:10.1101/gr.277246.122 · Cited by 31
ETS Transcription Factor Expression and Conversion During Prostate and Breast Cancer Progression
Watson, D. K., Turner, D. P., Scheiber, M. N., Findlay, V. J., & Watson, P. M. (2010) · The Open Cancer Journal · doi:10.2174/1874079001003010024 · Cited by 30
“ETS target gene specificity is provided by sequences flanking the core GGAA/T element, and functional activity is further modulated by posttranslational modification(s) [7] and interaction with other nuclear factors [8, 9].”
BackgroundSelf-citationCharacterization of the Human Insulin-induced Gene 2 (INSIG2) Promoter
Fernández-Álvarez, A. J., Álvarez, M. S., Cucarella, C., & Casado, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.067447 · Cited by 24
Acetylation impacts Fli‐1‐driven regulation of granulocyte colony stimulating factor
Richard, M. L., Brandon, D., Lou, N., Sato, S., Caldwell, T., Nowling, T. K., Gilkeson, G. S., & Zhang, X. K. (2016) · European Journal of Immunology · doi:10.1002/eji.201646315 · Cited by 24
MicroRNA 17-92 Cluster Mediates ETS1 and ETS2-Dependent RAS-Oncogenic Transformation
Kabbout, M., Dakhlallah, D. A., Sharma, S. M., Bronisz, A., Srinivasan, R., Piper, M. G., Marsh, C. B., & Ostrowski, M. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100693 · Cited by 25
“Ets1 and Ets2 share two highly conserved domains: the DNA binding domain at the C-terminal end, and the RAS/ERK activated Pointed domain at the N-terminal end [6–9].”
BackgroundZhang, G., Tian, X., Li, Y., Wang, Z.-Q., Li, X., & Zhu, C. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.029 · Cited by 22
Harel, S., Sánchez, V., Moamer, A., Sánchez-Galán, J. E., Hussein, M. N. A., Mayaki, D., Blanchette, M., & Hussain, S. N. A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.683651 · Cited by 22
“These interactions determine the transcriptional activities of ETS TFs in regulating distinct genes (Li et al., 2000), so it is possible that ETS1, ELK1, and ETV4 regulation of angiogenesis-related genes downstream from Tie-2 receptors is dependent on unique interactions with TFs other than those belonging to the ETS…”
BackgroundMechanisms Regulating Expression of the Tumor Necrosis Factor-related light Gene
Castellano, R., Lint, C. M. V., Péri, V., Veithen, E., Morel, Y., Costello, R. T., Olive, D., & Collette, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207689200 · Cited by 22
Listman, J. A., Wara-aswapati, N., Race, J. E., Blystone, L. W., Walker‐Kopp, N., Yang, Z., & Auron, P. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509143200 · Cited by 23
Factors Affecting EWS-FLI1 Activity in Ewing's Sarcoma
Herrero‐Martín, D., Fourtouna, A., Niedan, S., Riedmann, L. T., Schwentner, R., & Aryee, D. N. T. (2011) · Sarcoma · doi:10.1155/2011/352580 · Cited by 26
“factors bind predominantly as monomers to a GGAA/T core motif in promoter or enhancer regions of their target genes, functional interaction between ETS proteins and other factors is crucial to enhance or modulate DNA binding [75].”
BackgroundFunctional dissection of the ETS transcription factor MEF
Suico, M. A., Koyanagi, T., Ise, S., Lü, Z., Hisatsune, A., Seki, Y., Shuto, T., Isohama, Y., Miyata, T., & Kai, H. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00370-6 · Cited by 21
Wang, J., Mao, L., Parelkar, N. K., Tang, Q., Liu, Z., Sarwar, S., & Choe, E. S. (2003) · Current Neuropharmacology · doi:10.2174/1570159033360548 · Cited by 24
Shou, Z., Yamada, K., Inazu, T., Kawata, H., Hirano, S., Mizutani, T., Yazawa, T., Sekiguchi, T., Yoshino, M., Kajitani, T., et al. (2003) · Gene · doi:10.1016/s0378-1119(02)01093-4 · Cited by 21
“(Martin et al., 1992; Li et al., 2000; Yordy and Muise-Helmericks, 2000).”
BackgroundUtilising cottonseed in animal feeding: A dialectical perspective
Wang, W., Li, J., Liu, J., Ren, M., & Li, F. (2023) · Modern Agriculture · doi:10.1002/moda.16 · Cited by 20
Role of Ets Proteins in Development, Differentiation, and Function of T‐Cell Subsets
Liu, M., Gao, W., van Velkinburgh, J. C., Wu, Y., Ni, B., & Tian, Y. (2015) · Medicinal Research Reviews · doi:10.1002/med.21361 · Cited by 24
Deramaudt, T. B., Rémy, P., & Stiegler, P. (2001) · Gene · doi:10.1016/s0378-1119(01)00610-2 · Cited by 26
Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers
Wu, Y., Shi, L., Zhao, Y., Chen, P., Cui, R., Ji, M., He, N., Wang, M., Li, G., & Hou, P. (2021) · npj Precision Oncology · doi:10.1038/s41698-020-00140-5 · Cited by 24
Sequence-function correlations and dynamics of ERG isoforms. ERG8 is the black sheep of the family
Hoesel, B., Malkani, N., Hochreiter, B., Basílio, J., Sughra, K., Ilyas, M., & Schmid, J. A. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.10.023 · Cited by 23
“Furthermore, it is important to note that ERG-variants have the ability to form homo- or heterodimers generating an even higher functional diversity [18,19].”
BackgroundSong, K. S., Yoon, J.-H., Kim, K. S., & Ahn, D. W. (2012) · Mucosal Immunology · doi:10.1038/mi.2011.67 · Cited by 19
The transcription factor ETS1 in lymphomas: friend or foe?
Testoni, M., Chung, E. Y., Priebe, V., & Bertoni, F. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.981670 · Cited by 23
Ho, H. H., & Ivashkiv, L. B. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0046 · Cited by 18
Pub, a novel PU.1 binding protein, regulates the transcriptional activity of PU.1
Hirose, S., Nishizumi, H., & Sakano, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.212 · Cited by 21
Lv, Y., Sui, F., Ma, J., Ren, X., Yang, Q., Zhang, Y., Guan, H., Shi, B., Hou, P., & Ji, M. (2016) · Oncotarget · doi:10.18632/oncotarget.11154 · Cited by 19
“It is the fact that the DNA consensus sequences determined for the different ETS proteins are very similar, and thus their specific functions are dependent on other factors including interaction with other nuclear factors [29, 30].”
BackgroundProteomic Analysis of a PDEF Ets Transcription Factor-Interacting Protein Complex
Cho, J., Lee, M., Ahn, J., Park, E.-S., Cho, J.-H., Heo, S., Kim, B., Heo, S.-H., Park, H., Zerbini, L. F., et al. (2009) · Journal of Proteome Research · doi:10.1021/pr800683b · Cited by 18
Sugimoto, H., Sugimoto, S., Tatei, K., Obinata, H., Bakovic, M., Izumi, T., & Vance, D. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301590200 · Cited by 20
Olyha, S. J., O’Connor, S. K., Kribis, M., Bucklin, M. L., Kumar, D. B. U., Tyler, P. M., Alam, F., Jones, K. M., Sheikha, H., Konnikova, L., et al. (2024) · Journal of Clinical Immunology · doi:10.1007/s10875-023-01610-8 · Cited by 17
“…the observed phenotypes; deleterious mutations within the ETS DNA binding domain likely interfere with the ability of ELF4 to bind and initiate transcription at target genes, either directly or through interactions with other protein binding partners, as is common with ETS family members [51, 52].”
Broides, A., Ault, B. H., Arthus, M., Bichet, D. G., & Conley, M. E. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.05.001 · Cited by 18
Hong, M. J., Lee, S. Y., Choi, J. E., Jin, C., Kang, H. J., Baek, S. A., Lee, S. Y., Shin, K. M., Jeong, J. Y., Lee, W. K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7433 · Cited by 16
“…DNA sequence, binding of an ETS protein near other transcription factors or additional tissue-specific factors and the consequent interaction between them may result in either synergistic activation or repression of specific target genes, suggesting promoter and cell context specificity [29].”
Archer, L. K., Frame, F. M., & Maitland, N. J. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.05.006 · Cited by 18
Wang, X., Lv, J., Cheng, S., Su, Z., Qin, S., Sun, X., Tang, X., Liu, Q., Li, M., & Wang, X. (2022) · Pest Management Science · doi:10.1002/ps.7152 · Cited by 14
Transcriptional regulation of the proto‐oncogene Zfp521 by SPI1 (PU.1) and HOXC13
Yu, M., Aldallal, S., Al‐Haj, L., Panjwani, S., McCartney, A. S., Edwards, S. M., Manjunath, P., Walker, C., Awgulewitsch, A., & Hentges, K. E. (2016) · genesis · doi:10.1002/dvg.22963 · Cited by 18
“SPI1 binds to DNA as a monomer through its ETS-domain (Kodandapani et al., 1996), and also acts cooperatively with various other DNA binding proteins, including other ETS family transcription factors, to activate transcription of target genes (Li et al., 2000).”
BackgroundWardle, F. C., Wainstock, D. H., & Sive, H. L. (2002) · Development · doi:10.1242/dev.129.19.4387 · Cited by 17
Force, T. L., Haq, S., Kilter, H., & Michael, A. (2002) · Circulation · doi:10.1161/circ.105.4.402 · Cited by 19
Colomb, F., Krzewinski‐Recchi, M., Steenackers, A., Vincent, A., Harduin‐Lepers, A., Delannoy, P., & Groux‐Degroote, S. (2016) · Biochemical Journal · doi:10.1042/bcj20160602 · Cited by 13
“Different signaling pathways involving the MAP kinases ERK1/2, p38, JNK and PI3 kinases converge on the ETS transcription factors family, modulating their activity, protein interactions and downstream target genes (25).”
BackgroundTranscription Factors in the Development and Pro-Allergic Function of Mast Cells
Srivastava, M., & Kaplan, M. H. (2021) · Frontiers in Allergy · doi:10.3389/falgy.2021.679121 · Cited by 15
Martin, C. B., & Martin, B. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3123 · Cited by 13
“expression (41); thus, we examined cooperativity between the two”
BackgroundZhao, Q., Ren, Y., Xie, H., Yu, L., Lu, J., Jiang, W., Xiao, W., Zhu, Z., Wan, R., & Li, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.700192 · Cited by 13
PDEF downregulates stathmin expression in prostate cancer
Zhang, M. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1392 · Cited by 12
“Ets proteins control many important cellular processes, including proliferation, differentiation, angiogenesis and apoptosis (4-11).”
BackgroundThe Inferred Cardiogenic Gene Regulatory Network in the Mammalian Heart
Bazil, J. N., Stamm, K. D., Li, X., Thiagarajan, R., Nelson, T. J., Tomita-Mitchell, A., & Beard, D. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100842 · Cited by 8
High-Dose siRNAs Upregulate Mouse Eri-1 at both Transcription and Posttranscription Levels
Bian, Y., Zhou, W. L., Zhao, Y., Li, X., Geng, W., Hao, R., Yang, Q. K., & Huang, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026466 · Cited by 15
“Indeed, combinatorial control is a characteristic property of the Ets family members [24].”
BackgroundThe Ets protein Pointed P1 represses Asense expression in type II neuroblasts by activating Tailless
Chen, R., Deng, X., & Zhu, S. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1009928 · Cited by 18
“We reasoned that the lack of the phenotypes could be due to the missing of protein-protein interaction domains, which are common for Ets family proteins and essential for recruiting coactivators to activate target gene expression [37,38].”
BackgroundGenomic structure and promoter activity of the E1AF gene, a member of the ETS oncogene family
Ishida, S., Higashino, F., Aoyagi, M., Takahashi, A., Suzuki, T., Shindoh, M., Fujinaga, K., & Yoshida, K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.024 · Cited by 12
“The cooperative activation of various promoters by ETS family transcription factors and other transcription factors has been reported [25].”
BackgroundDNA-dependent protein kinase is a novel interaction partner for Ets-1 isoforms
Choul‐li, S., Drobecq, H., & Aumercier, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.059 · Cited by 14
Transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-A gene
Kumar, P., Arise, K. K., & Pandey, K. N. (2006) · Peptides · doi:10.1016/j.peptides.2006.01.004 · Cited by 13
Electrochemically monitoring the binding of concanavalin A and ovalbumin
Sugawara, K., Yugami, A., Kadoya, T., & Hosaka, K. (2011) · Talanta · doi:10.1016/j.talanta.2011.04.003 · Cited by 10
DNA Occupancy of Polymerizing Transcription Factors: A Chemical Model of the ETS Family Factor Yan
Hope, C. M., Rebay, I., & Reinitz, J. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2016.11.901 · Cited by 10
“Homo- or heterotypic dimerization is common amongTFs,with notable examples including helix-loophelix proteins (4), nuclear receptors (5), and TFs of the E26 transformation-specific (ETS) family (6).”
BackgroundMuthu, K., Panneerselvam, M., Muthukumaran, J., Topno, N. S., Das, A. A., & Ramadas, K. (2012) · Journal of Molecular Modeling · doi:10.1007/s00894-012-1489-x · Cited by 9
“The members of ETS family, binds with the specific promoter E-boxes (GGAA/T core motif) of their target genes [25] and regulates their transcription which in turn mediates various cellular events leading to the uncontrolled cellular growth.”
BackgroundYaniw, D., & Hu, J. (2005) · Cell Research · doi:10.1038/sj.cr.7290310 · Cited by 9
Wei, Y., Puzhko, S., Wabitsch, M., & Goodyer, C. G. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0190 · Cited by 13
“Interactions between CHOP and Ets1 Ets proteins have been shown to interact with several other transcription factors, including members of the basic-leucine zipper family to which CHOP belongs (26).”
BackgroundA light way for nuclear cell biologists
Forlani, G., & Ventura, B. D. (2020) · The Journal of Biochemistry · doi:10.1093/jb/mvaa139 · Cited by 10
Lim, J. H., Cho, J., Park, Y. B., Park, J., & Kwon, T. K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.102 · Cited by 8
Transactivation of lung lysozyme expression by Ets family member ESE-1
Lei, W., Jaramillo, R. J., & Harrod, K. S. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00130.2007 · Cited by 8
“Ets (E26 transforming specific) proteins are a superfamily of transcription factors containing a highly conserved “Ets domain” that recognizes the core motif GGA with specificities further defined by flanking nucleotide sequences (19, 27).”
BackgroundChoy, W. W., Datta, D., Geiger, C. A., Birrane, G., & Grant, M. A. (2013) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x13024795 · Cited by 8
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer
Rastogi, A., Tan, S., Mohamed, A. A., Chen, Y., Hu, Y., Petrovics, G., Sreenath, T., Kagan, J., Srivastava, S., McLeod, D. G., et al. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.25 · Cited by 8
“Venus constructs that contained either the N-terminus or C-terminus coding sequences of the Venus protein, linked to either TMPRSS2-ERG3 or TMPRSS2-ERG8 coding sequences were first evaluated, as they are known to homodimerize [33, 37].”
BackgroundAhn, J., Ko, M., Lee, K., Oh, J., Jeon, S. H., & Seong, R. H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.107 · Cited by 8
Zhu, J., Fei, Q., Wang, P., Lan, F., Mao, D. Q., Zhang, H. Y., & Yao, X. (2006) · Cell Research · doi:10.1038/sj.cr.7310092 · Cited by 8
Pickett, C. J., Gruner, H. N., & Davidson, B. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002169 · Cited by 6
Okamura, K., Yamashita, S., Ando, H., Horibata, Y., Aoyama, C., Takagishi, K., Izumi, T., Vance, D. E., & Sugimoto, H. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.12.016 · Cited by 6
Hope, C. M., Webber, J. L., Tokamov, S. A., & Rebay, I. (2018) · eLife · doi:10.7554/elife.37545 · Cited by 7
“Given the extensive evidence of physical associations between AP-1 TFs and ETS family factors in mammals (Li et al., 2000), these are prime candidates for exploration in the context of the yan mutants.”
BackgroundPakdel, F. D., Keramatipour, M., Noorbakhsh, F., Talebi, S., & Vodjgani, M. (2015) · PubMed · Cited by 5
Sood, A. K. (2009) · Immunologic Research · doi:10.1007/s12026-009-8129-2 · Cited by 5
“described in detail previously in several excellent reviews and reports [31–43].”
ResultBabal, Y. K., Sönmez, E., & Kurnaz, I. A. (2023) · Biosystems · doi:10.1016/j.biosystems.2023.104891 · Cited by 8
Dhulipala, P. D. K., Datta, P. K., Reddy, E. S. P., & Lianos, E. A. (2005) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2005.07.012 · Cited by 3
Epigenetic modifications of prostate-derived Ets transcription factor in breast cancer cells
Sabherwal, Y., Mahajan, N., & Zhang, M. (2013) · Oncology Reports · doi:10.3892/or.2013.2661 · Cited by 3
“Ets family members are characterized by an evolutionarily conserved DNA binding domain called the Ets domain and control key cellular processes, including proliferation, differentiation and apoptosis (6-10).”
BackgroundESE-1 in Early Development: Approaches for the Future
Lee, C. M., Wu, J., Xia, Y., & Hu, J. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00073 · Cited by 3
“Protein binding partners have been shown to be critical in regulating Ets factor function (reviewed in Li et al., 2000), but there is limited literature on ESE-1 binding partners, only identified through GST-pull down assays or immunoprecipitations in cell lines such as endothelial cells and 293T…”
BackgroundThe Role of ETS Transcriptional Regulation in Hormone Sensitive and Refractory Prostate Cancer
Turner, D. P. (2010) · The Open Cancer Journal · doi:10.2174/1874079001003010040 · Cited by 2
“Among the first characterized ETS interactions were studies demonstrating functional co-operativity between ETS factors (PEA3, ETS1, ERG) and the AP1 transcriptional complex in the up-regulation of uPA, MMP1, GM-CSF and TIMP1, all known mediators of cancer progression [51, 52].”
BackgroundRen, X., Song, L. J., Zhang, M., Zhang, W., Lin, K., & He, H. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/2762595 · Cited by 3
Silverman, N. (2006) · Digital Commons - University of South Florida (University of South Florida) · Cited by 2
Zhang, Y. (2006) · reroDoc Digital Library · Cited by 2
Suwa, Y., Nakamura, T., Toma, Š., Ikemizu, S., Kai, H., & Yamagata, Y. (2008) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309108002662 · Cited by 1
“Moreover, Ets-family members regulate gene transcription cooperatively with other transcription factors and cofactors through physical interactions on the promoters (Li et al., 2000).”
BackgroundLerch-Haner, J. K. (2008) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Hormonally Regulated Transcription Factors
Bolander, F. F. (2004) · Elsevier eBooks · doi:10.1016/b978-012111232-5/50013-0 · Cited by 2
Bachurski, C. J., & Trapnell, B. C. (2006) · Elsevier eBooks · doi:10.1016/b0-12-370879-6/00393-8 · Cited by 1
Kerkelä, R. (2003) · Cited by 1
Metadata
- Authors
- Li, R., Pei, H., & Watson, D. K.
- Affiliations
- Medical University of South Carolina (US)
- Venue
- Oncogene
- Published
- 2000-12-18
- Volume
- 19
- Issue
- 55
- Pages
- 6514-6523
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1969499006
- Semantic Scholar
- 55c1025171d826abcc152117a531ab2603e58604
- Cited by
- 229
- References
- 131
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 4 · 2022: 6 · 2021: 7 · 2020: 7 · 2019: 2 · 2018: 4 · 2017: 4 · 2016: 15 · 2015: 8 · 2014: 11 · 2013: 9 · 2012: 5
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Cancer Society
- National Institutes of Health
- National Cancer Institute (P01-CA78582, P01CA078582)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- ETS transcription factors, protein-protein interaction, ETS domain, transcriptional regulation, AP-1, NF-κB, Pax transcription factors, bHLH domain, bZIP domain, paired domain, subcellular localization, DNA binding, signal transduction
- MeSH terms
- Animals, Binding Sites, DNA, DNA-Binding Proteins, Gene Expression Regulation, Multigene Family, Humans, Mammals, Models, Genetic, Nuclear Proteins, Protein Binding, Proto-Oncogene Proteins, Transcription Factors, Transcription, Genetic, Trans-Activators, Retinoblastoma Protein, NF-kappa B, Consensus Sequence, Protein Structure, Tertiary, Transcription Factor AP-1, Dimerization, Amino Acid Motifs, Macromolecular Substances, Proto-Oncogene Proteins c-ets, Basic Helix-Loop-Helix Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.